Blood-brain barrier dysfunction in aging induces hyperactivation of TGFβ signaling and chronic yet reversible neural dysfunction.
Adult
Aged
Aged, 80 and over
Aging
/ pathology
Albumins
/ metabolism
Animals
Astrocytes
/ drug effects
Blood-Brain Barrier
/ drug effects
Chronic Disease
Cognitive Dysfunction
/ pathology
Gene Knockdown Techniques
Hippocampus
/ drug effects
Humans
Mice, Transgenic
Middle Aged
Protein Kinase Inhibitors
/ pharmacology
Receptor, Transforming Growth Factor-beta Type I
/ antagonists & inhibitors
Signal Transduction
Transforming Growth Factor beta
/ metabolism
Young Adult
Journal
Science translational medicine
ISSN: 1946-6242
Titre abrégé: Sci Transl Med
Pays: United States
ID NLM: 101505086
Informations de publication
Date de publication:
04 12 2019
04 12 2019
Historique:
received:
01
02
2019
revised:
15
07
2019
accepted:
07
11
2019
entrez:
6
12
2019
pubmed:
6
12
2019
medline:
12
9
2020
Statut:
ppublish
Résumé
Aging involves a decline in neural function that contributes to cognitive impairment and disease. However, the mechanisms underlying the transition from a young-and-healthy to aged-and-dysfunctional brain are not well understood. Here, we report breakdown of the vascular blood-brain barrier (BBB) in aging humans and rodents, which begins as early as middle age and progresses to the end of the life span. Gain-of-function and loss-of-function manipulations show that this BBB dysfunction triggers hyperactivation of transforming growth factor-β (TGFβ) signaling in astrocytes, which is necessary and sufficient to cause neural dysfunction and age-related pathology in rodents. Specifically, infusion of the serum protein albumin into the young rodent brain (mimicking BBB leakiness) induced astrocytic TGFβ signaling and an aged brain phenotype including aberrant electrocorticographic activity, vulnerability to seizures, and cognitive impairment. Furthermore, conditional genetic knockdown of astrocytic TGFβ receptors or pharmacological inhibition of TGFβ signaling reversed these symptomatic outcomes in aged mice. Last, we found that this same signaling pathway is activated in aging human subjects with BBB dysfunction. Our study identifies dysfunction in the neurovascular unit as one of the earliest triggers of neurological aging and demonstrates that the aging brain may retain considerable latent capacity, which can be revitalized by therapeutic inhibition of TGFβ signaling.
Identifiants
pubmed: 31801886
pii: 11/521/eaaw8283
doi: 10.1126/scitranslmed.aaw8283
pii:
doi:
Substances chimiques
Albumins
0
Protein Kinase Inhibitors
0
Transforming Growth Factor beta
0
Receptor, Transforming Growth Factor-beta Type I
EC 2.7.11.30
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, Non-P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NINDS NIH HHS
ID : R01 NS066005
Pays : United States
Organisme : NINDS NIH HHS
ID : R56 NS066005
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG042679
Pays : United States
Organisme : NIA NIH HHS
ID : F31 AG054147
Pays : United States
Commentaires et corrections
Type : CommentIn
Informations de copyright
Copyright © 2019 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.